Observational studyJournal of diabetes research2024

Usefulness of Once-Weekly GLP-1 Receptor Agonist Semaglutide on Glycemic Control in Subjects with Type 2 Diabetes Mellitus: Switching from the Same Class Dulaglutide in a Retrospective Observation Study.

Tomohiko Kimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.